SEC Filing Summary: Landec Corporation (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by Landec Corporation on July 21, 2004. The filing serves to announce the company's consolidated financial results for the fourth quarter and the full fiscal year ended May 30, 2004. The detailed financial data is contained in a press release attached as Exhibit 99.1.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are referenced as being included in the attached press release (Exhibit 99.1) but are not present in the body of this 8-K document.
Material Changes
The filing does not provide specific data regarding material changes versus prior periods. It solely references the issuance of the press release containing the results for the period ended May 30, 2004.
Guidance, Outlook, and Risks
The filing includes a standard disclaimer stating that the information contained in this Form 8-K and Exhibit 99.1 is not deemed "filed" for purposes of the Securities Exchange Act of 1934 and shall not be incorporated by reference into other filings. No specific guidance, outlook, management commentary, or risk factors are detailed in the text of this report.
Investor Verification Checklist
- Verify the specific revenue and net income figures in the attached Exhibit 99.1 press release.
- Confirm the company's cash position and debt levels as reported in the full fiscal year results.
- Review the press release for any forward-looking statements or guidance not included in this summary.
- Note that the registrant is Landec Corporation, not Lifecore Biomedical, Inc., as indicated in the metadata request.